# Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)

> **NCT02368171** · — · UNKNOWN · sponsor: **Southern California Institute for Research and Education** · enrollment: 60 (estimated)

## Conditions studied

- Obstructive Sleep Apnea
- Pulmonary Hypertension

## Interventions

- **OTHER:** measure exhaled carbon monoxide and nitric oxide

## Key facts

- **NCT ID:** NCT02368171
- **Lead sponsor:** Southern California Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2016-03
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02368171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02368171, "Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02368171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*